SCHEMBL8152104

SCHEMBL8152104

CCN(C(=O)c1cc2ccccc2[nH]1)C1CCCCC1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 1/20 0.52
TP53 P04637 1/20 0.51
NCOA1 Q15788 1/20 0.51
NCOA3 Q9Y6Q9 1/20 0.51
PYGL P06737 1/20 0.51
KDM4E B2RXH2 3/20 0.50
ALDH1A1 P00352 3/20 0.50
HSD17B10 Q99714 2/20 0.50
OPRK1 P41145 1/20 0.50
MAPT P10636 1/20 0.49
DAO P14920 1/20 0.49
HPGD P15428 1/20 0.49
SRD5A2 P31213 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.48
MDM2 Q00987 1/20 0.48
FAAH O00519 1/20 0.47
ALOX15 P16050 1/20 0.47
FLT3 P36888 1/20 0.47
MAOB P27338 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27024206 0.88 KDM4E (0.45) CCKBRPYGLKDM4EALDH1A1HSD17B10
SCHEMBL20320735 0.87 TRPM8 (0.51) CCKBRKDM4EHSD17B10MAPTDAO
SCHEMBL20305318 0.87 TRPM8 (0.51) CCKBRKDM4EHSD17B10MAPTDAO
SCHEMBL20320916 0.86 KDM4E (0.43) CCKBRTP53NCOA1NCOA3PYGL
SCHEMBL20320995 0.86 KDM4E (0.47) CCKBRPYGLKDM4EALDH1A1HSD17B10
SCHEMBL20321010 0.86 KDM4E (0.47) CCKBRPYGLKDM4EALDH1A1HSD17B10
SCHEMBL20321191 0.86 KDM4E (0.47) CCKBRPYGLKDM4EALDH1A1HSD17B10
SCHEMBL26004642 0.85 KDM4E (0.42) CCKBRTP53NCOA1NCOA3PYGL
SCHEMBL26004678 0.84 CCKBR (0.41) CCKBRTP53NCOA1NCOA3PYGL
SCHEMBL20320822 0.84 TP53 (0.48) CCKBRTP53NCOA1NCOA3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4306166-A2 COMPOUNDS, COMPOSITIONS AND METHODS OF USE Aquinnah Pharmaceuticals Inc. (US) 2024-01-17 EP disclosed
EP-3557998-B1 COMPOUNS, COMPOSITIONS AND METHODS OF USE AQUINNAH PHARMACEUTICALS INC (US) 2023-08-16 EP disclosed
WO-2018119395-A1 COMPOUNS, COMPOSITIONS AND METHODS OF USE AQUINNAH PHARMACEUTICALS, INC. (US) 2018-06-28 WO disclosed
EP-0983244-A1 TETRAHYDROISOQUINOLINE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS SMITHKLINE BEECHAM PLC (GB) 2000-03-08 EP disclosed
WO-1998050364-A1 TETRAHYDROISOQUINOLINE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS SMITHKLINE BEECHAM PLC (GB) 1998-11-12 WO disclosed